Exhibit 99.1 OnKure Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights BOULDER, CO, May 6, 2025 -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on developing novel precision medicines in oncology, today reported financial results for the quarter ended March 31, 2025, and provided business highlights. "OnKure looks to define a new standard of performance for precision targeted agents. We designed OKI-219 and our ongoing PIKture-01 ...